Astria Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Astria Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • Astria Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 57.8M shares, a 106% increase year-over-year.
  • Astria Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 30.1M shares, a 106% increase from 2022.
  • Astria Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 14.6M shares, a 63.8% increase from 2021.
  • Astria Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 8.93M shares, a 192% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 57.8M +29.8M +106% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 56.5M +28.5M +102% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 52.3M +24.4M +87.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 30.1M +15.5M +106% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-04
Q3 2023 28M +14.3M +104% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 28M +15M +115% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 27.9M +14.9M +115% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 14.6M +5.7M +63.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-04
Q3 2022 13.7M +912K +7.11% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 13M +7.04M +118% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 13M +9.29M +249% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 8.93M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 12.8M +9.59M +296% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 5.98M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 3.73M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 3.24M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.